Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹99 | ₹500 |
Expense Ratio | 0.64 | 1.72 |
NAV | ₹10.04 | ₹42.25 |
Fund Started | 15 Feb 2024 | 10 Oct 2018 |
Fund Size | ₹211.25 Cr | ₹8055.38 Cr |
Exit Load | Exit load of 0.05%, if redeemed within 15 Days. | Exit load for units in excess of 10% of the investment, 1% will be charged for redemption within 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -14.51% | -0.86% |
3 Year | - | 25.62% |
5 Year | - | 30.23% |
1 Year
3 Year
5 Year
Equity | 0.00% | 98.32% |
Cash | 100.00% | 1.68% |
Equity
Cash
Top 10 Holdings | - |
|
Top 10 Holdings
Name | Assets |
---|---|
Sai Life Sciences Ltd. | 5.28% |
Krishna Institute of Medical Sciences Ltd | 4.20% |
Swiggy Ltd. | 3.51% |
JK Lakshmi Cement Ltd. | 3.09% |
Multi Commodity Exchange Of India Ltd. | 3.00% |
Interglobe Aviation Ltd. | 2.83% |
Aditya Infotech Ltd. | 2.59% |
Delhivery Ltd. | 2.58% |
Global Health Ltd. | 2.58% |
Karur Vysya Bank Ltd. | 2.53% |
Name | Ekta Gala | Amit Nigam |
Start Date | 25 Feb 2025 | 09 Jul 2022 |
Name
Start Date
Description | The scheme seeks to provide long-term capital appreciation from a portfolio investing in units of Mirae Asset Nifty Smallcap 250 Momentum Quality 100 ETF. There is no assurance that the investment objective of the Scheme will be realized. | The scheme seeks to generate capital appreciation by investing predominantly in stocks of Smallcap companies. |
Launch Date | 15 Feb 2024 | 10 Oct 2018 |
Description
Launch Date